These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina. Payne AJ; Kaja S; Naumchuk Y; Kunjukunju N; Koulen P Int J Mol Sci; 2014 Jan; 15(2):1865-86. PubMed ID: 24473138 [TBL] [Abstract][Full Text] [Related]
12. Non-analgesic effects of opioids: neuroprotection in the retina. Husain S; Abdul Y; Potter DE Curr Pharm Des; 2012; 18(37):6101-8. PubMed ID: 22747547 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Strategies in Glaucoma. Gossman CA; Christie J; Webster MK; Linn DM; Linn CL Curr Pharm Des; 2016; 22(14):2178-92. PubMed ID: 26818878 [TBL] [Abstract][Full Text] [Related]
14. Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome. Johnson TV; DeKorver NW; Levasseur VA; Osborne A; Tassoni A; Lorber B; Heller JP; Villasmil R; Bull ND; Martin KR; Tomarev SI Brain; 2014 Feb; 137(Pt 2):503-19. PubMed ID: 24176979 [TBL] [Abstract][Full Text] [Related]
15. Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa. Brown C; Agosta P; McKee C; Walker K; Mazzella M; Alamri A; Svinarich D; Chaudhry GR Stem Cell Res Ther; 2022 Apr; 13(1):148. PubMed ID: 35395806 [TBL] [Abstract][Full Text] [Related]
16. Regulation of Excitatory Amino Acid Transmission in the Retina: Studies on Neuroprotection. Opere CA; Heruye S; Njie-Mbye YF; Ohia SE; Sharif NA J Ocul Pharmacol Ther; 2018; 34(1-2):107-118. PubMed ID: 29267132 [TBL] [Abstract][Full Text] [Related]
17. Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma. Kimura A; Guo X; Noro T; Harada C; Tanaka K; Namekata K; Harada T Neurosci Lett; 2015 Feb; 588():108-13. PubMed ID: 25555796 [TBL] [Abstract][Full Text] [Related]
18. Retinal Neuroprotective Effects of Flibanserin, an FDA-Approved Dual Serotonin Receptor Agonist-Antagonist. Coyner AS; Ryals RC; Ku CA; Fischer CM; Patel RC; Datta S; Yang P; Wen Y; Hen R; Pennesi ME PLoS One; 2016; 11(7):e0159776. PubMed ID: 27447833 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotection in glaucoma. Vishwaraj CR; Kavitha S; Venkatesh R; Shukla AG; Chandran P; Tripathi S Indian J Ophthalmol; 2022 Feb; 70(2):380-385. PubMed ID: 35086201 [TBL] [Abstract][Full Text] [Related]